Drug intelligence / Profile preview

N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide

Development stage: Unknown
Modality: Small Molecules

Overview

N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide is an experimental small molecule compound with the molecular formula C19H21N3O3S and a molecular weight of approximately 371.45 g/mol[2][6][7]. It functions as an inhibitor of carbonic anhydrase 2, a zinc metalloenzyme involved in the reversible hydration of carbon dioxide. By inhibiting this enzyme, the compound may affect physiological processes such as pH regulation, fluid secretion (notably in the eye), and bone resorption[6][9]. The compound has not been approved for any therapeutic use and is primarily used in research settings to study carbonic anhydrase inhibition[6][7].

Other names: N-[(2S)-2-(1H-indol-5-yl)butyl]-4-sulfamoylbenzamide

Targets

CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide.

Explore the full profile